Filter News
Area of Research
News Topics
- (-) Biomedical (1)
- (-) Computer Science (2)
- (-) Materials Science (2)
- (-) Microscopy (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (5)
- Bioenergy (2)
- Coronavirus (1)
- Decarbonization (1)
- Fusion (6)
- Isotopes (4)
- Molten Salt (1)
- Nanotechnology (1)
- Neutron Science (2)
- Nuclear Energy (17)
- Physics (2)
- Quantum Science (2)
- Space Exploration (2)
- Sustainable Energy (2)
- Transformational Challenge Reactor (3)
Media Contacts
Scientists at ORNL and the University of Nebraska have developed an easier way to generate electrons for nanoscale imaging and sensing, providing a useful new tool for material science, bioimaging and fundamental quantum research.
Scientists at the Department of Energy Manufacturing Demonstration Facility at ORNL have their eyes on the prize: the Transformational Challenge Reactor, or TCR, a microreactor built using 3D printing and other new approaches that will be up and running by 2023.
With Tennessee schools online for the rest of the school year, researchers at ORNL are making remote learning more engaging by “Zooming” into virtual classrooms to tell students about their science and their work at a national laboratory.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have developed a new method to peer deep into the nanostructure of biomaterials without damaging the sample. This novel technique can confirm structural features in starch, a carbohydrate important in biofuel production.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.